醋酸泼尼松龙结构式
|
常用名 | 醋酸泼尼松龙 | 英文名 | Prednisolone Acetate |
---|---|---|---|---|
CAS号 | 52-21-1 | 分子量 | 402.481 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | 579.8±50.0 °C at 760 mmHg | |
分子式 | C23H30O6 | 熔点 | 240-244 °C | |
MSDS | 中文版 美版 | 闪点 | 198.4±23.6 °C | |
符号 |
GHS06 |
信号词 | Danger |
醋酸泼尼松龙用途Prednisolone 21-acetate是肾上腺皮质激素类药物, 具有抗炎、抗过敏和抑制免疫等多种药理作用。 |
中文名 | 1,4-孕甾二烯-11β,17α,21-三醇-3,20-二酮 21-醋酸酯 |
---|---|
英文名 | Prednisolone Acetate |
中文别名 | 21-乙酰氧基-1,4-孕甾二烯-11β,17α-二醇-3,20-二酮 | 醋酸泼尼松龙 |
英文别名 | 更多 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 579.8±50.0 °C at 760 mmHg |
熔点 | 240-244 °C |
分子式 | C23H30O6 |
分子量 | 402.481 |
闪点 | 198.4±23.6 °C |
精确质量 | 402.204254 |
PSA | 100.90000 |
LogP | 2.58 |
外观性状 | 白色结晶粉末 |
蒸汽压 | 0.0±3.7 mmHg at 25°C |
折射率 | 1.587 |
储存条件 | 本品应密封于阴凉干燥处保存。 |
稳定性 | Stable. Incompatible with strong oxidizing agents. |
分子结构 | 1、 摩尔折射率:105.06 2、 摩尔体积(cm3/mol):312.5 3、 等张比容(90.2K):855.5 4、 表面张力(dyne/cm):56.1 5、 极化率(10-24cm3):41.65 |
计算化学 | 1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:2 3.氢键受体数量:6 4.可旋转化学键数量:4 5.互变异构体数量:6 6.拓扑分子极性表面积101 7.重原子数量:29 8.表面电荷:0 9.复杂度:827 10.同位素原子数量:0 11.确定原子立构中心数量:7 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1. 性状:无色结晶粉末。无臭。味苦。 2. 密度(g/mL,25/4℃): 未确定 3. 相对蒸汽密度(g/mL,空气=1):未确定 4. 熔点(ºC):237-239 5. 沸点(ºC,常压):未确定 6. 沸点(ºC,5.2kPa):未确定 7. 折射率:未确定 8. 闪点(ºC):未确定 9. 比旋光度(º):未确定 10. 自燃点或引燃温度(ºC):未确定 11. 蒸气压(kPa,25ºC):未确定 12. 饱和蒸气压(kPa,60ºC):未确定 13. 燃烧热(KJ/mol):未确定 14. 临界温度(ºC):未确定 15. 临界压力(KPa):未确定 16. 油水(辛醇/水)分配系数的对数值:未确定 17. 爆炸上限(%,V/V):未确定 18. 爆炸下限(%,V/V):未确定 19. 溶解性:不溶于水,溶于乙醇,微溶于氯仿、丙酮。 |
醋酸泼尼松龙毒理学数据: 1、急性毒性:大鼠皮下LD50:>240mg/kg;小鼠皮下LD50:3500mg/kg 2、生殖毒性:雌性大鼠经口TDLo:1800mg/kg,2-19天后受孕;雌性小鼠皮下TDLo:96g/kg,11天后受孕; 雌性小鼠静脉TDLo:96mg/kg,11-14天后受孕 |
~% 醋酸泼尼松龙 52-21-1 |
文献:Hogg et al. Journal of the American Chemical Society, 1955 , vol. 77, p. 4436 |
~% 醋酸泼尼松龙 52-21-1 |
文献:The Upjohn Company Patent: US5426198 A1, 1995 ; |
~% 醋酸泼尼松龙 52-21-1 |
文献:Herzog et al. Journal of the American Chemical Society, 1955 , vol. 77, p. 4781,4783 |
~% 醋酸泼尼松龙 52-21-1 |
文献:Florey; Restivo Journal of Organic Chemistry, 1957 , vol. 22, p. 406,408 |
醋酸泼尼松龙上游产品 5 | |
---|---|
醋酸泼尼松龙下游产品 10 | |
可由乙酸氢化可的松用微生物或二氧化硒脱氢而制得
海关编码 | 2937210000 |
---|
Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension.
J. Pharm. Biomed. Anal. 102 , 261-6, (2015) A new stability indicating reversed phase high performance liquid chromatography (RP-HPLC) method was developed and validated under current International Conference of Harmonisation (ICH) guidance for... |
|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with β-cyclodextrins
Bioorg. Med. Chem. 17 , 896-904, (2009) This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret... |
|
Investigation of Overrun-Processed Porous Hyaluronic Acid Carriers in Corneal Endothelial Tissue Engineering.
PLoS ONE 10 , e0136067, (2015) Hyaluronic acid (HA) is a linear polysaccharide naturally found in the eye and therefore is one of the most promising biomaterials for corneal endothelial regenerative medicine. This study reports, fo... |
Pregna-1,4-diene-3,20-dione, 21- (acetyloxy)-11,17-dihydroxy-, (11β)- |
(11b)-21-(Acetyloxy)-11,17-dihydroxypregna-1,4-diene-3,20-dione |
acétate de 2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-diméthyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodécahydro-3H-cyclopenta[a]phénanthrén-17-yl]-2-oxoéthyle |
Scherisolon |
EINECS 200-134-1 |
Prednisolone acetate |
11b,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate |
Ak-Tate |
Pregna-1,4-diene-3,20-dione, 11β,17,21-trihydroxy-, 21-acetate (8CI) |
Prednisolone-21-acetate |
MFCD00037710 |
Deltacortenolo |
(11β)-11,17-Dihydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate |
2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate |
2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethylacetat |
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11β)- |
Hydrocortidelt |